[ad_1]
While Covid-19 vaccine development studies continue in the world, some countries entered the storage race. If the greed for vaccines doesn’t end, those living in low-income countries may have to wait until 2024 for the right vaccines to arrive. Especially wealthy countries are claimed to be dissatisfied with enough vaccines for their populations and have already made a treaty for vaccines that have not yet been tested on subjects or are awaiting approval.
TAKE MORE POPULATION
The United States ordered a total of more than 1 billion, the EU 1 billion 425 million, Canada 358 million, the United Kingdom 355 million, Japan 290 million, Australia 134 million 800 thousand doses of vaccine. Canada has made enough claims to vaccinate its population about 5 times and the UK about 3 times. A London-based analytics firm announced that the companies lowered their short-term production targets. Pfizer-Biontech, AstraZeneca and Moderna are believed to produce enough vaccines for approximately 3 billion people by the end of 2021, and Russia for 500 million. Most of the vaccine production capacities announced so far have been acquired. It is noted that rich countries, which make up a very small portion of the world’s population, have already ordered 53% of vaccines that show promise for the future. Experts, for their part, affirm that there will be a surplus of vaccines and ask rich countries to share vaccines with other countries. It is predicted that if vaccines are not distributed “evenly” among countries, the epidemic could kill more people.
32 BILLION DOLLARS INJECTED INTO THE CASE
As the world battles coronavirus, it is claimed that Pfizer, which is cooperating with the American pharmaceutical giant and German biotech company BioNTech, and the American biotech company Moderna will earn a total of $ 32 billion in 2021 from the sale of the vaccines. that produce. Morgan Stanley stated that while Pfizer’s vaccine earnings this year were $ 975 million, it would generate an additional $ 9.3 billion in 2022-2023. Pfizer will share its profits with the German company BioNTech. Moderna is also expected to make $ 13.2 billion. Among analyst estimates, Moderna will earn between $ 10 and $ 15 billion in 2021 and 2022.
Turkey
